Bayer Invests in Contraceptives Production
Bayer’s pharmaceuticals division is spending more than €400 million to expand its production facilities for contraceptives in low and middle-income countries, in partnership with international organizations such as the United Nations Population Fund and the United States Agency for International Development.
